Publication: İdiopatik Trombositopenik Purpuralı Bir Olguda Eltrombopag Kullanımı ile İlişkili İskemik İnme
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Idiopatik trombositopenik purpura (ITP) tedavisinde kul- lanılmakta olan eltrombopag gibi trombopoetin reseptör (TpoR) agonistlerinin iskemik serebrovasküler hastalık oluşturma riski nadir görülmektedir. 5 yıldır ITP tanısı ile takip edilen sağ hemiparezi ve afazi kliniği ile acil servi- se başvuran hastaya yapılan tetkikler sonucunda iskemik serebrovasküler hastalık tanısı konuldu. Olguda serebro- vasküler hastalığın etyolojisi eltrombopag ile ilişkilendiril- di. Bu olgunun nadir görülmesi nedeniyle literatür eşliğin- de tartışıldı.
Thrombopoetin receptor agonists like eltrombopag, used for Idiopathic Thrombocytopenic Purpura treatment rarely cause to the ischemic cerebrovascular disease. In this re- port, a patient, have been followed by ITP diagnosis for 5 years, admitted to the emergency service for right hemi- paresis and aphasia. It was diagnosed as ischemic cere- brovascular disease. Etiology of patients cerebrovascu- lar event was associated with eltrombopag. Because of this rare seen situation, it was argued by in the light of the literature.
Thrombopoetin receptor agonists like eltrombopag, used for Idiopathic Thrombocytopenic Purpura treatment rarely cause to the ischemic cerebrovascular disease. In this re- port, a patient, have been followed by ITP diagnosis for 5 years, admitted to the emergency service for right hemi- paresis and aphasia. It was diagnosed as ischemic cere- brovascular disease. Etiology of patients cerebrovascu- lar event was associated with eltrombopag. Because of this rare seen situation, it was argued by in the light of the literature.
Description
Keywords
Citation
WoS Q
Scopus Q
Source
Volume
43
Issue
1
Start Page
171
End Page
173
